LivaNova has announced the commercial launch of Platinum, a new range of implantable cardiac defibrillators (ICDs) and cardiac resynchronisation therapy devices (CRT-Ds).
According to LivaNova, the Platinum range offers unmatched longevity. It is designed to consume extremely low levels of electricity, and is projected to last over 14 years for the single-chamber ICD model, over 13 years for the dual-chamber ICD model, and over 10 years for CRT-D devices, in standard functioning.
The longevity of Platinum aims to limit the number of device replacements, minimising the risks that are inherent in replacement surgeries.
Platinum’s size ranges from 31cc to 33cc, and the Ergoform design of the can, with its rounded shape and smooth edges was designed to facilitate the implant procedure and improve patient comfort, claims the company.
According to LivaNova, Platinum devices also feature proven therapeutic functions such as PARAD+, a best-in-class arrhythmia discrimination algorithm, SafeR, a pacing mode which preserves natural heart conduction and SonR, the only hemodynamic sensor which automatically optimises CRT settings.
“It’s clear that there is a growing mismatch between patient life expectancy and the longevity of ICD and CRT-D devices”, says Philippe Ritter, Hôpital Cardiologique du Haut Levêque, University of Bordeaux, France. “This leads to a very high rate of replacement which can generate major complications for patients and significant associated costs. This is a serious issue for patients and Platinum, with an expected service life of over 14 years, addresses this gap.”
